462 related articles for article (PubMed ID: 20170482)
1. Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening.
Webb DR; Khunti K; Srinivasan B; Gray LJ; Taub N; Campbell S; Barnett J; Henson J; Hiles S; Farooqi A; Griffin SJ; Wareham NJ; Davies MJ
Trials; 2010 Feb; 11():16. PubMed ID: 20170482
[TBL] [Abstract][Full Text] [Related]
2. A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study.
Simmons RK; Borch-Johnsen K; Lauritzen T; Rutten GE; Sandbæk A; van den Donk M; Black JA; Tao L; Wilson EC; Davies MJ; Khunti K; Sharp SJ; Wareham NJ; Griffin SJ
Health Technol Assess; 2016 Aug; 20(64):1-86. PubMed ID: 27583404
[TBL] [Abstract][Full Text] [Related]
3. Screening for type 2 diabetes: a short report for the National Screening Committee.
Waugh NR; Shyangdan D; Taylor-Phillips S; Suri G; Hall B
Health Technol Assess; 2013 Aug; 17(35):1-90. PubMed ID: 23972041
[TBL] [Abstract][Full Text] [Related]
4. Let's prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation.
Gray LJ; Khunti K; Williams S; Goldby S; Troughton J; Yates T; Gray A; Davies MJ;
Cardiovasc Diabetol; 2012 May; 11():56. PubMed ID: 22607160
[TBL] [Abstract][Full Text] [Related]
5. Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study.
Webb DR; Gray LJ; Khunti K; Srinivasan B; Taub N; Campbell S; Barnett J; Farooqi A; Echouffo-Tcheugui JB; Griffin SJ; Wareham NJ; Davies MJ
Diabetologia; 2011 Sep; 54(9):2237-46. PubMed ID: 21638133
[TBL] [Abstract][Full Text] [Related]
6. The ADDITION-Cambridge trial protocol: a cluster -- randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients.
Echouffo-Tcheugui JB; Simmons RK; Williams KM; Barling RS; Prevost AT; Kinmonth AL; Wareham NJ; Griffin SJ
BMC Public Health; 2009 May; 9():136. PubMed ID: 19435491
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial.
Griffin SJ; Rutten GEHM; Khunti K; Witte DR; Lauritzen T; Sharp SJ; Dalsgaard EM; Davies MJ; Irving GJ; Vos RC; Webb DR; Wareham NJ; Sandbæk A
Lancet Diabetes Endocrinol; 2019 Dec; 7(12):925-937. PubMed ID: 31748169
[TBL] [Abstract][Full Text] [Related]
8. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial.
Simmons RK; Echouffo-Tcheugui JB; Sharp SJ; Sargeant LA; Williams KM; Prevost AT; Kinmonth AL; Wareham NJ; Griffin SJ
Lancet; 2012 Nov; 380(9855):1741-8. PubMed ID: 23040422
[TBL] [Abstract][Full Text] [Related]
9. The Reversal Intervention for Metabolic Syndrome (TRIMS) study: rationale, design, and baseline data.
Dunkley AJ; Davies MJ; Stone MA; Taub NA; Troughton J; Yates T; Khunti K
Trials; 2011 May; 12():107. PubMed ID: 21542913
[TBL] [Abstract][Full Text] [Related]
10. Intensive versus standard multifactorial cardiovascular risk factor control in screen-detected type 2 diabetes: 5-year and longer-term modelled outcomes of the ADDITION-Leicester study.
Webb D; Dales J; Zaccardi F; Hill S; Moore C; Farooqi A; Griffin S; Davies M; Khunti K
Diabetes Metab Res Rev; 2019 Mar; 35(3):e3111. PubMed ID: 30521699
[TBL] [Abstract][Full Text] [Related]
11. Study Protocol: The Norfolk Diabetes Prevention Study [NDPS]: a 46 month multi - centre, randomised, controlled parallel group trial of a lifestyle intervention [with or without additional support from lay lifestyle mentors with Type 2 diabetes] to prevent transition to Type 2 diabetes in high risk groups with non - diabetic hyperglycaemia, or impaired fasting glucose.
Pascale M; Murray N; Bachmann M; Barton G; Clark A; Howe A; Greaves C; Sampson M
BMC Public Health; 2017 Jan; 17(1):31. PubMed ID: 28056894
[TBL] [Abstract][Full Text] [Related]
12. Record-based, stepwise screening for type 2 diabetes integrated into an annual cardiovascular care review system: Findings from a UK general practice.
Fisher BG; Ang YL; Goodhart C; Simmons RK
Prim Care Diabetes; 2011 Dec; 5(4):265-9. PubMed ID: 21968319
[TBL] [Abstract][Full Text] [Related]
13. HeLP-Diabetes: randomised controlled trial protocol.
Murray E; Dack C; Barnard M; Farmer A; Li J; Michie S; Pal K; Parrott S; Ross J; Sweeting M; Wood B; Yardley L
BMC Health Serv Res; 2015 Dec; 15():578. PubMed ID: 26715038
[TBL] [Abstract][Full Text] [Related]
14. PRomotion Of Physical activity through structured Education with differing Levels of ongoing Support for people at high risk of type 2 diabetes (PROPELS): study protocol for a randomized controlled trial.
Yates T; Griffin S; Bodicoat DH; Brierly G; Dallosso H; Davies MJ; Eborall H; Edwardson C; Gillett M; Gray L; Hardeman W; Hill S; Morton K; Sutton S; Troughton J; Khunti K
Trials; 2015 Jul; 16():289. PubMed ID: 26130075
[TBL] [Abstract][Full Text] [Related]
15. A cluster randomized controlled trial of the effectiveness and cost-effectiveness of intermediate care clinics for diabetes (ICCD): study protocol for a randomized controlled trial.
Armstrong N; Baines D; Baker R; Crossman R; Davies M; Hardy A; Khunti K; Kumar S; O'Hare JP; Raymond N; Saravanan P; Stallard N; Szczepura A; Wilson A;
Trials; 2012 Sep; 13():164. PubMed ID: 22971356
[TBL] [Abstract][Full Text] [Related]
16. Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study.
Gray LJ; Tringham JR; Davies MJ; Webb DR; Jarvis J; Skinner TC; Farooqi AM; Khunti K
Vasc Health Risk Manag; 2010 Oct; 6():837-42. PubMed ID: 20957129
[TBL] [Abstract][Full Text] [Related]
17. Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy.
Krass I; Carter R; Mitchell B; Mohebbi M; Shih STF; Trinder P; Versace VL; Wilson F; Namara KM
BMJ Open; 2017 Dec; 7(12):e017725. PubMed ID: 29284715
[TBL] [Abstract][Full Text] [Related]
18. Screening for type 2 diabetes: literature review and economic modelling.
Waugh N; Scotland G; McNamee P; Gillett M; Brennan A; Goyder E; Williams R; John A
Health Technol Assess; 2007 May; 11(17):iii-iv, ix-xi, 1-125. PubMed ID: 17462167
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
